FDA Needs To Track Actions Built On Supplement AERs – GAO Report
This article was originally published in The Tan Sheet
Executive Summary
A GAO report says FDA “may be able to expand” its use of supplement adverse event reports if it can track its use of the data to support actions it takes to protect consumers. The report makes five key recommendations for the agency to improve its approach to AERs.
You may also be interested in...
McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
FDA regulations exempt retailers from compiling supplement adverse event reports, even for products that bear a store brand. Private label firms or contract manufacturers are required to receive AERs linked to those products and to forward reports of serious events to FDA within 15 days.
McCaskill Not Sold On Retailer Exemption From Supplement AER Filing
FDA regulations exempt retailers from compiling supplement adverse event reports, even for products that bear a store brand. Private label firms or contract manufacturers are required to receive AERs linked to those products and to forward reports of serious events to FDA within 15 days.
Durbin’s DoD Supplement Proposal Could Be ‘Back Door’ To Pre-market Approval Rule
The Illinois senator proposes an amendment to the National Defense Authorization Act that would require third-party verification for supplements sold at any commissary or other retail store operating on a DoD installation.